Studies have shown GLP-1 medications have other health benefits, including lowering the risk of certain diseases and addictions, like drinking and smoking.

Some health experts have call for further investigation, as figures show 82 deaths with suspected links to slimming drugs ...

Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of obesity ...

Weight loss drugs linked to dozens of deaths - The medical director of the NHS has warned of the side effects of weight loss ...

Eli Lilly was second to the lucrative GLP-1 market for diabetes and obesity following its chief metabolic medicine rival Novo ...

We recently published a list of Top 10 Stocks to Buy According to Sustainable Insight Capital Management. In this article, we ...

Ozempic, Mounjaro and Wegovy may not be the lightbulb, jet airplane or internet, but their impact is expected to be so ...

Sustainable Insight Capital Management (SICM) focuses on institutional investments, offering both long-only and long-short ...

The FDA has now resolved the shortages of Novo Nordisk’s and Eli Lilly’s blockbuster weight-loss drugs, which could spell the ...

Shares of Hims & Hers Health plunged Friday after the Food & Drug Administration said a shortage of the active ingredient in ...

A new study has linked the active ingredients in these drugs — semaglutide (Ozempic) and tirzepatide (Mounjaro ... leading to sudden vision loss. While the exact cause remains unclear ...